Natixis Advisors’s Global Cord Blood Corporation CO Stock Holding History

Natixis Advisors’s Portfolio CO Stock Details CO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-200,914	Closed	-$211K	–	1550
2023 Q2	$211K	Sell	200,914 -237	-0.1%	-$249	﹤0.01%	1460
2023 Q1	$601K	Hold	201,151	–	–	﹤0.01%	1267
2022 Q4	$601K	Hold	201,151	–	–	﹤0.01%	1265
2022 Q3	$601K	Buy	201,151 +1,271	+0.6%	+$3.12K	﹤0.01%	1242
2022 Q2	$592K	Buy	199,880 +10,550	+6%	+$32.7K	﹤0.01%	1241
2022 Q1	$729K	Buy	189,330 +11,709	+7%	+$48.6K	﹤0.01%	1203
2021 Q4	$744K	Buy	177,621 +3,052	+2%	+$13K	﹤0.01%	1176
2021 Q3	$815K	Buy	174,569 +3,680	+2%	+$18.1K	﹤0.01%	1124
2021 Q2	$913K	Hold	170,889	–	–	﹤0.01%	1113
2021 Q1	$774K	Buy	+170,889	New	+$741K	﹤0.01%	1100

Other funds holding CO

RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

Operose Advisors Milwaukee, Wisconsin $431M AUM 20.45% 1-Year Est. Return

Natixis Advisors's CO Position: Q3 2023 in Review

Natixis Advisors sold out of Global Cord Blood Corporation (CO) in Q3 2023, closing a stake of 200,914 shares — an estimated $211K sold.

Natixis Advisors first reported a position in CO in Q1 2021 and held it in 10 quarters. The position peaked at $913K in Q2 2021. 2 funds tracked by Wall St. Rank hold CO as of Q3 2023.

Natixis Advisors reported no remaining Global Cord Blood Corporation position as of Q3 2023 after selling out during the quarter.
Natixis Advisors sold 200,914 Global Cord Blood Corporation shares in Q3 2023, an estimated $211K.
Natixis Advisors first reported a position in Global Cord Blood Corporation in Q1 2021 and held it in 10 quarters.
Natixis Advisors's Global Cord Blood Corporation position peaked at $913K in Q2 2021.
2 funds tracked by Wall St. Rank held Global Cord Blood Corporation as of Q3 2023.

Based on Natixis Advisors's 13F filing for Q3 2023, filed 13 Nov 2023.